Company news

Relay Therapeutics, Inc. news in 2024

Relay Therapeutics, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Relay Therapeutics Announces Updated Interim Data for RLY-2608 + Fulvestrant Demonstrating Continued Maturation of Clinically Meaningful Progression Free Survival

December 10, 2024

Relay Therapeutics to Present Updated Clinical Data on RLY-2608 in HR+/HER2- Breast Cancer at 2024 San Antonio Breast Cancer Symposium

December 8, 2024

Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors

December 2, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences

November 6, 2024

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

November 5, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024

October 29, 2024

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

September 9, 2024

Relay Therapeutics Announces Proposed Public Offering of Common Stock

September 8, 2024

Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

September 8, 2024

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024

September 5, 2024

Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

August 5, 2024

Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024

July 29, 2024

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event

June 5, 2024

Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

June 4, 2024

Relay Therapeutics to Host New Program and Platform Event on June 6, 2024

May 12, 2024

Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

May 1, 2024

Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024

April 24, 2024

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

February 25, 2024

Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

February 21, 2024

Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024

February 14, 2024

Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

January 31, 2024

Relay Therapeutics Announces $30 Million Private Placement Financing

January 7, 2024

Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

January 1, 2024

Decks in 2024